SR NIACIN VERSUS IHN: LIPID-ALTERING AND METABOLIC EFFECTS

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。这项为期6周的双盲随机研究的目的是比较安慰剂SR烟酸和IHN在改善心脏健康、促进正常胆固醇水平和减少心脏健康饮食副作用方面的能力。我们的目标是更多地了解两种常见的非处方烟酸制剂对心血管疾病的影响。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The intent of this double-blind randomized 6-week study is to compare to placebo SR niacin's and IHN's abilities to improve heart health, promote normal cholesterol levels and minimize side effects when coupled with a heart-healthy diet. Our goal is to learn more about the CVD-related effects of two common over-the-counter preparations to niacin.